---
pmid: '24684931'
title: The Vasa Homolog RDE-12 engages target mRNA and multiple argonaute proteins
  to promote RNAi in C. elegans.
authors:
- Shirayama M
- Stanney W 3rd
- Gu W
- Seth M
- Mello CC
journal: Curr Biol
year: '2014'
full_text_available: false
pmcid: PMC4017897
doi: 10.1016/j.cub.2014.03.008
---

# The Vasa Homolog RDE-12 engages target mRNA and multiple argonaute proteins to promote RNAi in C. elegans.
**Authors:** Shirayama M, Stanney W 3rd, Gu W, Seth M, Mello CC
**Journal:** Curr Biol (2014)
**DOI:** [10.1016/j.cub.2014.03.008](https://doi.org/10.1016/j.cub.2014.03.008)
**PMC:** [PMC4017897](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4017897/)

## Abstract

1. Curr Biol. 2014 Apr 14;24(8):845-51. doi: 10.1016/j.cub.2014.03.008. Epub 2014
 Mar 27.

The Vasa Homolog RDE-12 engages target mRNA and multiple argonaute proteins to 
promote RNAi in C. elegans.

Shirayama M(1), Stanney W 3rd(2), Gu W(2), Seth M(1), Mello CC(3).

Author information:
(1)Program in Molecular Medicine, University of Massachusetts Medical School, 
368 Plantation Street, Worcester, MA 01605, USA; RNA Therapeutics Institute, 
University of Massachusetts Medical School, 368 Plantation Street, Worcester, MA 
01605, USA; Howard Hughes Medical Institute, University of Massachusetts Medical 
School, 368 Plantation Street, Worcester, MA 01605, USA.
(2)Program in Molecular Medicine, University of Massachusetts Medical School, 
368 Plantation Street, Worcester, MA 01605, USA; RNA Therapeutics Institute, 
University of Massachusetts Medical School, 368 Plantation Street, Worcester, MA 
01605, USA.
(3)Program in Molecular Medicine, University of Massachusetts Medical School, 
368 Plantation Street, Worcester, MA 01605, USA; RNA Therapeutics Institute, 
University of Massachusetts Medical School, 368 Plantation Street, Worcester, MA 
01605, USA; Howard Hughes Medical Institute, University of Massachusetts Medical 
School, 368 Plantation Street, Worcester, MA 01605, USA. Electronic address: 
craig.mello@umassmed.edu.

Argonaute (AGO) proteins are key nuclease effectors of RNAi. Although purified 
AGOs can mediate a single round of target RNA cleavage in vitro, accessory 
factors are required for small interfering RNA (siRNA) loading and to achieve 
multiple-target turnover. To identify AGO cofactors, we immunoprecipitated the 
C. elegans AGO WAGO-1, which engages amplified small RNAs during RNAi. These 
studies identified a robust association between WAGO-1 and a conserved Vasa 
ATPase-related protein RDE-12. rde-12 mutants are deficient in RNAi, including 
viral suppression, and fail to produce amplified secondary siRNAs and certain 
endogenous siRNAs (endo-siRNAs). RDE-12 colocalizes with WAGO-1 in germline P 
granules and in cytoplasmic and perinuclear foci in somatic cells. These 
findings and our genetic studies suggest that RDE-12 is first recruited to 
target mRNA by upstream AGOs (RDE-1 and ERGO-1), where it promotes small RNA 
amplification and/or WAGO-1 loading. Downstream of these events, RDE-12 forms an 
RNase-resistant (target mRNA-independent) complex with WAGO-1 and may thus have 
additional functions in target mRNA surveillance and silencing.

Copyright Â© 2014 Elsevier Ltd. All rights reserved.

DOI: 10.1016/j.cub.2014.03.008
PMCID: PMC4017897
PMID: 24684931 [Indexed for MEDLINE]
